Mesenchymal stem cells negatively regulate dendritic lineage commitment of umbilical-cord-blood-derived hematopoietic stem cells: An unappreciated mechanism as immunomodulators

Tissue Engineering - Part A

Volumn 16, Issue 9, 2010, Pages 2987-2997

  Lai, Hsiu Yu ^a   Yang, Ming Jie ^b   Wen, Kuo Chang ^b   Chao, Kuan Chong ^b   Shih, Chu Chih ^c   Lee, Oscar K ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEATH; FETAL MONITORING; FLOWCHARTING; GRAFTING (CHEMICAL); METADATA; STEM CELLS;

APOPTOSIS; CLINICAL APPLICATION; CO-CULTURES; DENDRITIC CELLS; DIRECT CONTACT; GRAFT-VERSUS-HOST DISEASE; HEMATOPOIETIC STEM CELLS; IMMUNOMODULATORS; INTERLEUKIN-6; MESENCHYMAL STEM CELL; MODULATING FUNCTIONS; MONOPHOSPHATES; T-CELL RESPONSE; TRANSFORMING GROWTH FACTORS; TUMOR NECROSIS FACTORS; UP-REGULATION;

CELL CULTURE;

CYTOKINE; LIPOPOLYSACCHARIDE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; COCULTURE; CYTOLOGY; DENDRITIC CELL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; LIPOPOLYSACCHARIDES; MESENCHYMAL STEM CELLS;

EID: 77956083256     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0731     Document Type: Article

References (45)

1. Friedenstein, A.J., Gorskaja, J.F., and Kulagina, N.N. Fibro-blast precursors in normal and irradiated mouse hemato-poietic organs. Exp Hematol 4, 267, 1976.
2. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., Du, J., Aldrich, S., Lisberg, A., Low, W.C., Largaespada, D.A., and Verfaillie, C.M. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41, 2002.
3. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
4. Aggarwal, S., and Pittenger, M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815, 2005.
5. Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M., and Ringden, O. Treatment of severe acute graft-versus-host disease with third party hap-loidentical mesenchymal stem cells. Lancet 363, 1439, 2004.
6. Ringden, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lonnies, H., Marschall, H.U., Dlugosz, A., Szakos, A., Hassan, Z., Omazic, B., Aschan, J., Barkholt, L., and Le Blanc, K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 81, 1390, 2006.
7. Fang, B., Song, Y., Liao, L., Zhang, Y., and Zhao, R.C. Favorable response to human adipose tissue-derived mes-enchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplant Proc 39, 3358, 2007.
8. Brooke, G., Cook, M., Blair, C., Han, R., Heazlewood, C., Jones, B., Kambouris, M., Kollar, K., McTaggart, S., Peleka-nos, R., Rice, A., Rossetti, T., and Atkinson, K. Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol 18, 846, 2007.
9. Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M.E., Re-mberger, M., Dini, G., Egeler, R.M., Bacigalupo, A., Fibbe, W., and Ringden, O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371, 1579, 2008.
10. Crop, M., Baan, C., Weimar, W., and Hoogduijn, M. Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation. Transpl Int 22, 365, 2009.
11. Zhang, X., Jiao, C., and Zhao, S. Role of mesenchymal stem cells in immunological rejection of organ transplantation. Stem Cell Rev 5, 402, 2009.
12. Nasef, A., Ashammakhi, N., and Fouillard, L. Im-munomodulatory effect of mesenchymal stromal cells: possible mechanisms. Regen Med 3, 531, 2008.
13. Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., Galun, E., and Rachmilewitz, J. Human mes-enchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105, 2214, 2005.
14. Sato, K., Ozaki, K., Oh, I., Meguro, A., Hatanaka, K., Nagai, T., Muroi, K., and Ozawa, K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109, 228, 2007.
15. Tse, W.T., Pendleton, J.D., Beyer, W.M., Egalka, M.C., and Guinan, E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389, 2003.
16. Krampera, M., Glennie, S., Dyson, J., Scott, D., Laylor, R., Simpson, E., and Dazzi, F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101, 3722, 2003.
17. Guinan, E.C., Gribben, J.G., Boussiotis, V.A., Freeman, G.J., and Nadler, L.M. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84, 3261, 1994.
18. Steinman, R.M., and Nussenzweig, M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 99, 351, 2002.
19. Mills, K.H. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4, 841, 2004.
20. Fu, L., Zhu, L., Huang, Y., Lee, T.D., Forman, S.J., and Shih, C.C. Derivation of neural stem cells from mesenchymal stemcells: evidence for a bipotential stem cell population. Stem Cells Dev 17, 1109, 2008.
21. Li, Y.P., Paczesny, S., Lauret, E., Poirault, S., Bordigoni, P., Mekhloufi, F., Hequet, O., Bertrand, Y., Ou-Yang, J.P., Stoltz, J.F., Miossec, P., and Eljaafari, A. Human mesen-chymal stem cells license adult CD34\+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J Immunol 180, 1598, 2008.
22. Nauta, A.J., Kruisselbrink, A.B., Lurvink, E., Willemze, R., and Fibbe, W.E. Mesenchymal stem cells inhibit generation and function of both CD34\+-derived and monocyte-derived dendritic cells. J Immunol 177, 2080, 2006.
23. Chen, L., Zhang, W., Yue, H., Han, Q., Chen, B., Shi, M., Li, J., Li, B., You, S., Shi, Y., and Zhao, R.C. Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34\+ cells. Stem Cells Dev 16, 719, 2007.
24. Negrotto, S., Pacienza, N., D'Atri, L.P., Pozner, R.G., Mala-ver, E., Torres, O., Lazzari, M.A., Gomez, R.M., and Schattner, M. Activation of cyclic AMP pathway prevents CD34(\+) cell apoptosis. Exp Hematol 34, 1420, 2006.
25. Suda, T., and Arai, F. Wnt signaling in the niche. Cell 132, 729, 2008.
26. Jiang, X.X., Zhang, Y., Liu, B., Zhang, S.X., Wu, Y., Yu, X.D., and Mao, N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105, 4120, 2005.
27. Wodnar-Filipowicz, A. Flt3 ligand: role in control of hema-topoietic and immune functions of the bone marrow. News Physiol Sci 18, 247, 2003.
28. Ito, T., Inaba, M., Inaba, K., Toki, J., Sogo, S., Iguchi, T., Adachi, Y., Yamaguchi, K., Amakawa, R., Valladeau, J., Saeland, S., Fukuhara, S., and Ikehara, S. A CD1a\+/CD11c\+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. J Immunol 163, 1409, 1999.
29. Jaksits, S., Kriehuber, E., Charbonnier, A.S., Rappersberger, K., Stingl, G., and Maurer, D. CD34\+ cell-derived CD14\+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. J Immunol 163, 4869, 1999.
30. Graziani-Bowering, G.M., and Filion, L.G. Down regulation of CD4 expression following isolation and culture of human monocytes. Clin Diagn Lab Immunol 7, 182, 2000.
31. Muench, M.O., Roncarolo, M.G., and Namikawa, R. Phe-notypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver. Blood 89, 1364, 1997.
32. Torii, K., Nishizawa, K., Kawasaki, A., Yamashita, Y., Ka-tada, M., Ito, M., Nishimoto, I., Terashita, K., Aiso, S., and Matsuoka, M. Anti-apoptotic action of Wnt5a in dermal fi-broblasts is mediated by the PKA signaling pathways. Cell Signal 20, 1256, 2008.
33. Zhou, J., Cheng, P., Youn, J.I., Cotter, M.J., and Gabrilovich, D.I. Notch and wingless signaling cooperate in regulation of dendritic cell differentiation. Immunity 30, 845, 2009.
34. Shortman, K., and Naik, S.H. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7, 19, 2007.
35. Zeytun, A., van Velkinburgh, J.C., Pardington, P.E., Cary, R.R., and Gupta, G. Pathogen-specific innate immune response. Adv Exp Med Biol 598, 342, 2007.
36. Conti, L., Cardone, M., Varano, B., Puddu, P., Belardelli, F., and Gessani, S. Role of the cytokine environment and cy-tokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes. Eur J Immunol 38, 750, 2008.
37. Chevrel, G., Granet, C., and Miossec, P. Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappaB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann Rheum Dis 64, 1257, 2005.
38. Fadilah, S.A., Vuckovic, S., Khalil, D., and Hart, D.N. Cord blood CD34\+ cells cultured with FLT3L, stem cell factor, interleukin-6, and IL-3 produce CD11c\+CD1a-/c-myeloid dendritic cells. Stem Cells Dev 16, 849, 2007.
39. Liang, S., Ristich, V., Arase, H., Dausset, J., Carosella, E.D., and Horuzsko, A. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6\STAT3 signaling pathway. Proc Natl Acad Sci USA 105, 8357, 2008.
40. Hegde, S., Pahne, J., and Smola-Hess, S. Novel immuno-suppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression. FASEB J 18, 1439, 2004.
41. Mathew, J.M., and Miller, J. Immunoregulatory role of chi-merism in clinical organ transplantation. Bone Marrow Transplant 28, 115, 2001.
42. Fandrich, F., Lin, X., Chai, G.X., Schulze, M., Ganten, D., Bader, M., Holle, J., Huang, D.S., Parwaresch, R., Zavazava, N., and Binas, B. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 8, 171, 2002.
43. De Pauw, L., Toungouz, M., and Goldman, M. Infusion of donor-derived hematopoietic stem cells in organ transplantation: clinical data. Transplantation 75, 46S, 2003.
44. Herve, P. Donor-derived hematopoietic stem cells in organ transplantation: technical aspects and hurdles yet to be cleared. Transplantation 75, 55S, 2003.
45. Rifle, G., and Mousson, C. Donor-derived hematopoietic cells in organ transplantation: a major step toward allograft tolerance? Transplantation 75, 3S, 2003.